Cefotetan Disodium

头孢替坦二钠

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameCefotetan Disodium
Drug Alias NameCefotetanum头胞替坦双硫唑甲氧头孢菌素头孢双硫唑甲氧头孢替坦 +[10] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsBronchiectasisUrinary Tract InfectionsSkin Diseases, Infectious +[10] 
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1985/12/27
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesTeligent
China Registration ClassN/A

Develop Information

Active CompaniesOregon Health And Science UniversityPharmaceutical Associates IncHikma Pharmaceuticals +[6] 
Inactive CompaniesYangtze River Pharmaceutical (Group) Co Ltd
Active IndicationsUrinary Tract InfectionsSkin Diseases, InfectiousRespiratory Tract Infections +[6] 
Inactive IndicationsBronchiectasisPneumoniaBronchitis, Chronic +[4] 

Other Information

ATC CodeJ01DC05
Related LinksWikipediaDrugBankKEGG